603 related articles for article (PubMed ID: 30593954)
1. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
2. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation.
Wu Q; Gao C; Wang H; Zhang X; Li Q; Gu Z; Shi X; Cui Y; Wang T; Chen X; Wang X; Luo C; Tao L
Int J Biochem Cell Biol; 2018 Jan; 94():44-55. PubMed ID: 29174311
[TBL] [Abstract][Full Text] [Related]
3. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Nah SY; Jeong JH; Byun JK; Ko SK; Bing G; Hong JS; Kim HC
J Neuroinflammation; 2018 Feb; 15(1):52. PubMed ID: 29467000
[TBL] [Abstract][Full Text] [Related]
5. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis.
Wu H; Zhao Y; Huang Q; Cai M; Pan Q; Fu M; An X; Xia Z; Liu M; Jin Y; He L; Shang J
FASEB J; 2018 Jun; 32(6):3193-3214. PubMed ID: 29430989
[TBL] [Abstract][Full Text] [Related]
6. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
7. Substance P excites GABAergic neurons in the mouse central amygdala through neurokinin 1 receptor activation.
Sosulina L; Strippel C; Romo-Parra H; Walter AL; Kanyshkova T; Sartori SB; Lange MD; Singewald N; Pape HC
J Neurophysiol; 2015 Oct; 114(4):2500-8. PubMed ID: 26334021
[TBL] [Abstract][Full Text] [Related]
8. Irisin Rescues Blood-Brain Barrier Permeability following Traumatic Brain Injury and Contributes to the Neuroprotection of Exercise in Traumatic Brain Injury.
Guo P; Jin Z; Wang J; Sang A; Wu H
Oxid Med Cell Longev; 2021; 2021():1118981. PubMed ID: 34697562
[TBL] [Abstract][Full Text] [Related]
9. Substance P promotes the recovery of oxidative stress-damaged retinal pigmented epithelial cells by modulating Akt/GSK-3β signaling.
Baek SM; Yu SY; Son Y; Hong HS
Mol Vis; 2016; 22():1015-23. PubMed ID: 27582624
[TBL] [Abstract][Full Text] [Related]
10. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
[TBL] [Abstract][Full Text] [Related]
11. Substance P enhances the local activation of NK
Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
[TBL] [Abstract][Full Text] [Related]
12. Deletion of NADPH oxidase 4 reduces severity of traumatic brain injury.
Ma MW; Wang J; Dhandapani KM; Brann DW
Free Radic Biol Med; 2018 Mar; 117():66-75. PubMed ID: 29391196
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl fumarate treatment after traumatic brain injury prevents depletion of antioxidative brain glutathione and confers neuroprotection.
Krämer T; Grob T; Menzel L; Hirnet T; Griemert E; Radyushkin K; Thal SC; Methner A; Schaefer MKE
J Neurochem; 2017 Dec; 143(5):523-533. PubMed ID: 28921587
[TBL] [Abstract][Full Text] [Related]
14. Two affinities for a single antagonist at the neuronal NK1 tachykinin receptor: evidence from quantitation of receptor endocytosis.
Jenkinson KM; Southwell BR; Furness JB
Br J Pharmacol; 1999 Jan; 126(1):131-6. PubMed ID: 10051129
[TBL] [Abstract][Full Text] [Related]
15. Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury.
Liu YL; Xu ZM; Yang GY; Yang DX; Ding J; Chen H; Yuan F; Tian HL
Acta Pharmacol Sin; 2017 Nov; 38(11):1445-1455. PubMed ID: 28770828
[TBL] [Abstract][Full Text] [Related]
16. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
17. NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
Leonard AV; Thornton E; Vink R
PLoS One; 2014; 9(5):e98364. PubMed ID: 24859234
[TBL] [Abstract][Full Text] [Related]
18. Low-Molecular-Weight Fucoidan Attenuates Mitochondrial Dysfunction and Improves Neurological Outcome After Traumatic Brain Injury in Aged Mice: Involvement of Sirt3.
Wang T; Zhu M; He ZZ
Cell Mol Neurobiol; 2016 Nov; 36(8):1257-1268. PubMed ID: 26743530
[TBL] [Abstract][Full Text] [Related]
19. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
20. The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.
Sorby-Adams AJ; Marcoionni AM; Dempsey ER; Woenig JA; Turner RJ
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28817088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
